Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.
about
Advanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approachesFunctional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancersCurrent role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinomaHigher micronutrient intake is associated with human papillomavirus-positive head and neck cancer: a case-only analysisThe impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisComprehensive analysis of DNA methylation in head and neck squamous cell carcinoma indicates differences by survival and clinicopathologic characteristicsManagement of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neckTransoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors.HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North AmericansDownregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival.Human Papilloma Virus (HPV) in head and neck region: review of literature.Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence.High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methods.Independent prognostic role of human papillomavirus genotype in cervical cancer.Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study.Psychosocial functioning and vascular endothelial growth factor in patients with head and neck cancer.Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma.Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancerMeta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).Clinical and scientific impact of human papillomavirus on head and neck cancer.HPV-associated head and neck cancer: a virus-related cancer epidemic.Oral epithelial stem cells - implications in normal development and cancer metastasis.Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesisWeekly chemotherapy with radiation versus high-dose cisplatin with radiation as organ preservation for patients with HPV-positive and HPV-negative locally advanced squamous cell carcinoma of the oropharynx.Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.Development and evaluation of a PCR and mass spectroscopy (PCR-MS)-based method for quantitative, type-specific detection of human papillomavirusDifferential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer.Circulating CD4-positive lymphocyte levels as predictor of response to induction chemotherapy in patients with advanced laryngeal cancerThe contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancerChemoselection: a paradigm for optimization of organ preservation in locally advanced larynx cancerHuman Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK populationClinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.Impact of HPV infection on the clinical outcome of p-CAIR trial in head and neck cancer.Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis.A novel curcumin analog (H-4073) enhances the therapeutic efficacy of cisplatin treatment in head and neck cancerInduction of CD44 variant 9-expressing cancer stem cells might attenuate the efficacy of chemoradioselection and Worsens the prognosis of patients with advanced head and neck cancerNovel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: an analysis of the TAX 324 trial.Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinoma
P2860
Q26767046-58E97E7D-26EE-4D45-933B-178DADE4A812Q26866157-6BF875A5-4FB7-4345-8E98-90E8D3FA678AQ26991953-2A11A852-060F-44F1-8B9D-4C95DBDE1328Q28386178-A5E49BFB-F849-4996-9BF4-28EE9EAE4840Q28388257-57268F69-15AB-4900-97A1-D2B6A460B0BDQ28485279-BE474CA5-C919-449E-BE6F-CA890C520877Q30252081-E9EA50B4-A8AA-4A23-A389-202AE6059088Q33388183-F22F71E9-95FD-4A75-A0B9-06EC4265BCFAQ33477468-D629005B-65C2-4B91-A0F6-3E4381EB2D04Q33503791-4B40CEFD-FA90-4670-A3C6-0E076A1D54F2Q33566949-C34C5789-5AD6-441F-A8BF-79B354AD88FAQ33626377-FED37B24-CB8C-442D-B37E-D8FC3A044FD8Q33658257-304815A3-5951-4512-A67A-655A9DE14F8DQ33726331-42DA4361-DB3C-4C16-96B8-1ACDCF1CD3C2Q33768243-B703C61F-D0EE-453A-8E7D-E4E0B2E8273DQ33809636-1A9D7D95-65CC-40F2-86E6-06474C4AAD2CQ33905994-F858F600-777B-498D-A931-821C55A5B021Q33918767-14A632BB-EF49-4724-B5AF-E1A3DA12563BQ33986942-A8A946BC-2580-493C-99BC-64B104F95595Q34011808-F38D9B6F-64E3-4011-92FC-BEC7C551565AQ34031281-9D671F7E-5791-4C2F-BC24-B9F16B562FDBQ34114152-01748B08-8D1C-4995-B931-1F94E39D115CQ34147649-C830E264-589C-4854-912E-27E8846BE36FQ34282049-1EA4E341-3D60-493C-8037-5142B0CF541EQ34385645-EE228DE9-5385-4A58-A6DB-E0399B18E741Q34394972-092D8DCE-E5A7-4B5B-960E-0FFBD9AA7783Q34420904-4DF65069-87FC-4CEA-9238-562E07F7C296Q34554185-ACA713CC-254E-4249-9071-F5725B96EAF6Q34569283-70DF2324-4A38-46B4-9D54-233568B2D921Q34622547-16DC9D3F-E035-4C16-A73C-8D5B3E14E257Q34691622-647850F4-3A89-4FBA-8BE5-1F6CC232B831Q34698871-6770E8DC-E23A-4EAF-8038-2C918C364057Q34757933-CA5E0E49-B2FE-4F94-B98F-7ED928B51786Q34768545-E66D64DA-B236-47EE-A07B-51A2B007F5D3Q34951384-A9BEB774-FABA-40F9-BB61-BA29D182F346Q35124426-797764F7-0457-43EF-829F-AC2BC756AF5BQ35133375-D9BB7BA4-2D75-46BF-9897-9673E090BCC2Q35159155-A115EC81-85AB-4D03-BEE4-7A5331D7C917Q35174609-84A74D2C-70D7-477A-A9AA-19BC3C9F4DACQ35214908-09329451-C627-4286-960C-EAE07DF2346A
P2860
Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemoselection as a strategy f ...... ciated with HPV16 copy number.
@en
Chemoselection as a strategy f ...... ciated with HPV16 copy number.
@nl
type
label
Chemoselection as a strategy f ...... ciated with HPV16 copy number.
@en
Chemoselection as a strategy f ...... ciated with HPV16 copy number.
@nl
prefLabel
Chemoselection as a strategy f ...... ciated with HPV16 copy number.
@en
Chemoselection as a strategy f ...... ciated with HPV16 copy number.
@nl
P2093
P2860
P356
P1476
Chemoselection as a strategy f ...... ciated with HPV16 copy number.
@en
P2093
Bhavna Kumar
Carol R Bradford
Christina I Tsien
David M Kurnit
Douglas B Chepeha
Francis P Worden
Gregory T Wolf
Heidi L Mason
Jeremy M G Taylor
Julia S Lee
P2860
P304
P356
10.1200/JCO.2007.12.7597
P407
P577
2008-05-12T00:00:00Z